CABIO(SH:688089) Xin Lang Cai Jing·2025-10-31 05:40Group 1 - The core viewpoint of the news is that 嘉必优 has shown a mixed performance in stock price and financial results, with a notable increase in revenue and net profit year-on-year [1][2][3] Group 2 - 嘉必优's stock price increased by 2.01% to 24.36 CNY per share, with a total market capitalization of 4.1 billion CNY [1] - The company has experienced a year-to-date stock price increase of 29.37%, but has seen a decline of 6.09% over the past 20 days and 7.45% over the past 60 days [1] - For the period from January to September 2025, 嘉必优 achieved a revenue of 428 million CNY, representing a year-on-year growth of 10.56%, and a net profit of 129 million CNY, reflecting a year-on-year increase of 54.18% [2] - The main business revenue composition includes 76.16% from ARA products, 21.24% from DHA products, and 2.60% from other supplements [2] - As of September 30, 2025, 嘉必优 had 8,362 shareholders, with an average of 20,127 circulating shares per person [2] - The company has distributed a total of 243 million CNY in dividends since its A-share listing, with 103 million CNY distributed in the last three years [3]